Salvage treatment after first-line docetaxel

All patients who receive docetaxel-based chemotherapy for CRPC will progress, thus, there have been many clinical trials investigating the role of salvage chemotherapy. Several groups have used second-line intermittent docetaxel re-treatment in patients who had clearly responded to first-line docetaxel. In general, a PSA response can be achieved in about 60% of patients with a median time to progression of about 6 months, while treatment-associated toxicity is minimal and similar to that of first-line docetaxel.

http://www.semanticweb.org/ontologies/2018/1/ProstateCancer.owl#Salvage_treatment_after_first-line_docetaxel

一线多西他赛后补救治疗

All patients who receive docetaxel-based chemotherapy for CRPC will progress, thus, there have been many clinical trials investigating the role of salvage chemotherapy. Several groups have used second-line intermittent docetaxel re-treatment in patients who had clearly responded to first-line docetaxel. In general, a PSA response can be achieved in about 60% of patients with a median time to progression of about 6 months, while treatment-associated toxicity is minimal and similar to that of first-line docetaxel.

Salvage treatment after first-line docetaxel

ProstateCancer:Salvage_treatment_after_first-line_docetaxel

Salvage treatment after first-line docetaxel

http://www.semanticweb.org/ontologies/2018/1/ProstateCancer.owl#Castration-resistant_prostate_cancer(CRPC)